| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 15.997 | 23.327 | 27.437 | 30.702 | 28.265 | 41.548 | 44.198 | 61.496 | 73.009 |
| Total Income - EUR | - | 15.997 | 23.327 | 27.437 | 30.702 | 28.287 | 41.548 | 44.198 | 61.496 | 73.009 |
| Total Expenses - EUR | - | 7.533 | 8.350 | 12.469 | 16.608 | 12.651 | 10.077 | 10.722 | 22.371 | 19.992 |
| Gross Profit/Loss - EUR | - | 8.464 | 14.977 | 14.968 | 14.094 | 15.636 | 31.471 | 33.476 | 39.125 | 53.017 |
| Net Profit/Loss - EUR | - | 7.983 | 14.277 | 14.145 | 13.173 | 14.896 | 30.478 | 32.405 | 38.526 | 50.871 |
| Employees | - | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Agf Derm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 47 | 582 | 3.770 | 13.318 | 9.495 | 11.909 | 7.904 | 4.348 | 2.777 |
| Current Assets | - | 8.850 | 13.924 | 10.625 | 11.635 | 26.429 | 29.426 | 42.576 | 47.234 | 49.410 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 1.795 | 1.329 | 1.835 | 2.192 | 3.409 | 3.184 | 27.749 | 31.947 | 5.784 |
| Cash | - | 7.055 | 12.595 | 8.790 | 9.443 | 23.020 | 26.241 | 14.827 | 15.287 | 43.626 |
| Shareholders Funds | - | 8.028 | 14.340 | 14.196 | 24.877 | 34.948 | 41.244 | 32.454 | 38.575 | 50.919 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.018 | 293 | 301 | 267 | 1.151 | 269 | 18.259 | 13.231 | 1.576 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Agf Derm Srl